Sakar Healthcare P/B Ratio
Sakar Healthcare P/B ratio. Sakar Healthcare (SAKAR) P/B ratio is 6.67 (High), book value per share ₹147.73 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Sakar Healthcare screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SAKAR P/B Ratio — Valuation Insights & Book Value Analysis
Sakar Healthcare price-to-book ratio interpretation, valuation status and historical context — current P/B 6.67 (High). Browse Sakar Healthcare financial data for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PB of 6.67, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 36.7% above historical average
- Trading at premium to sector average PB of -0.3
Sakar Healthcare P/B Ratio Historical Trend
SAKAR annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read SAKAR ex-dividend dates for the complete payout history and dividend yield track record.
SAKAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Sakar Healthcare annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 6.61 | ₹147.73 | ₹976.20 | ₹325 | High |
| 2025 | 3.15 | ₹130.0 | ₹409.20 | ₹286 | High |
SAKAR vs Healthcare Peers — P/B Ratio Comparison
Sakar Healthcare P/B 6.67 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |